# Etomidate Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 18
- Latest FDA row update: 08/20/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Caplin Steriles, Ltd. — Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) — FDA availability: Available — updated: 06/16/2026
- Caplin Steriles, Ltd. — Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) — FDA availability: Available — updated: 06/16/2026
- Caplin Steriles, Ltd. — Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) — FDA availability: Available — updated: 06/16/2026
- Caplin Steriles, Ltd. — Etomidate, Injection, 2mg/mL (NDC 65219-447-20) — FDA availability: Available — updated: 06/16/2026
- Eugia US LLC — Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) — FDA availability: Unavailable — updated: 08/06/2026
- Eugia US LLC — Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) — FDA availability: Unavailable — updated: 08/06/2026
- Gland Pharma Limited — Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) — FDA availability: Available — updated: 07/22/2026
- Gland Pharma Limited — Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) — FDA availability: Available — updated: 07/22/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) — FDA availability: Available — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) — FDA availability: Available — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) — FDA availability: Available — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) — FDA availability: Available — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) — FDA availability: Available — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) — FDA availability: Available — updated: 08/13/2026
- Hospira, Inc., a Pfizer Company — Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) — FDA availability: Unavailable — updated: 08/07/2026
- Mylan Institutional, a Viatris Company — Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) — FDA availability: Available — updated: 08/20/2026
- Mylan Institutional, a Viatris Company — Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) — FDA availability: Available — updated: 08/20/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/etomidate-injection)
- [JSON record](https://citefacts.com/shortages/etomidate-injection.json)